Patent · US Active

Co-crystal of etravirine and nicotinamide

US8754093B2 · kind B2 · utility

0Cited by

0References

22Claims

0Family size

Assignee

Janssen R & D Ireland · IE

Inventors

Matthew Sansone · Dracut, US
Mark Tawa · Watertown, US
Julius F. Remenar · Framingham, US
Lieven Elvire Colette Baert · Brugge, BE

Key dates

Filing date	Mar 26, 2010
Grant date	Jun 17, 2014
Priority date	—
Expiry date	Dec 21, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/48
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Etravirine (TMC125) nicotinamide co-crystal, its preparation, and use in the treatment of HIV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.